Nonspecific effects in longitudinal studies: Impact on quality of life measures

被引:72
作者
Bouchet, C
Guillemin, F
Briancon, S
机构
[1] School of Public Health, Faculty of Medicine, Nancy
[2] School of Public Health, Faculty of Medicine
关键词
placebo effect; Hawthorne effect; measurement; quality of life; longitudinal study; clinical trial;
D O I
10.1016/0895-4356(95)00540-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A variety of factors may influence outcome measures in longitudinal studies, including pla; cebo, Hawthorne, or natural history effects. Quality of life (Qol) measures are particularly subject to these phenomena. This 2-month postal survey was set up to examine the extent of nonspecific effects in a treatment (vitamin supplementation) group (n = 180), a placebo group (n = 180), as part of a stratified, randomized controlled trial, and two control groups (n = 768 each). Quality of life was measured using the SF36. The placebo effect had a significant impact on improving physical, mental, and pain dimensions (p = 0.02 to 0.04), and the Hawthorne effect was significant (p = 0.03 to 0.009) for psychological dimensions. Although the impact of natural history was not significant, it tended to worsen all Rot dimensions. Vitamin supplementation had no effect on Rot. These results demonstrate the importance of placebo and Hawthorne effects and suggest that they may be responsible for misleading results or reductions in the power of controlled trials.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 28 条
[1]  
Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949
[2]  
[Anonymous], PDQ EPIDEMIOLOGY
[3]  
CHINN S, 1989, REV EPIDEMIOL SANTE, V37, P431
[4]   EFFECT OF REGRESSION TO MEAN IN EPIDEMIOLOGIC AND CLINICAL STUDIES [J].
DAVIS, CE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1976, 104 (05) :493-498
[5]   RANDOMIZATION BY GROUP IN STUDYING THE EFFECT OF DRUG INFORMATION IN PRIMARY CARE [J].
DIWAN, VK ;
ERIKSSON, B ;
STERKY, G ;
TOMSON, G .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (01) :124-130
[6]  
DIXON WJ, 1992, BMDP STATISTICAL SOF
[7]   QUALITY-OF-LIFE MEASURES IN HEALTH-CARE .1. APPLICATIONS AND ISSUES IN ASSESSMENT [J].
FITZPATRICK, R ;
FLETCHER, A ;
GORE, S ;
JONES, D ;
SPIEGELHALTER, D ;
COX, D .
BRITISH MEDICAL JOURNAL, 1992, 305 (6861) :1074-1077
[8]   MEASUREMENT OF QUALITY OF LIFE IN CLINICAL-TRIALS OF THERAPY [J].
FLETCHER, AE ;
BULPITT, CJ .
CARDIOLOGY, 1988, 75 :41-52
[9]  
FLETCHER RH, 1984, CLIN EPIDEMIOLOGY ES, P127
[10]  
Goldstein H, 1979, DESIGN ANAL LONGITUD